drug discovery | pharmaphorum

Friday 5 December 2025

drug discovery

News

Merck gets stuck on Proxygen’s molecular glue degraders

Proxygen has added another big pharma company to its list of partners, with Merck & Co the latest to be snared by its molecular glue degrader technology.

News

BenevolentAI lead atopic dermatitis drug misses the mark

BenevolentAI lead atopic dermatitis drug misses the mark

BenevolentAI has reported disappointing results in a phase 2 trial of lead drug BEN-2293 in atopic dermatitis (AD), as the drug was unable to show the hoped-for effect on

News

Japanese pharmas sign up to use new AI supercomputer

Japanese pharmas sign up to use new AI supercomputer

Mitsui, NVIDIA's Tokyo-1 supercomputer, aims to turbocharge Japan’s use of AI in drug discovery

News

Exscientia builds cancer pipeline with two BMS drugs

Exscientia builds cancer pipeline with two BMS drugs

LSD1 and MALT1 inhibitors inherited from BMS alliance will be biotech's next cancer candidates.

News

Merck makes its Foundry data tools available for free

Merck makes its Foundry data tools available for free

Library of tools made for Palantir's Foundry is now on the Github open-source code repository.

Digital

pharmaphorum podcast episode 77

Solving problems in pathology data, with Nathan Buchbinder

Jonah Comstock chats with Nathan Buchbinder, co-founder and chief product officer at Proscia.